Celon Pharma SA (CLN) — Tangible Net Worth Ratio
Celon Pharma SA (CLN) has a Tangible Net Worth Ratio of 96.0% as of March 2026. This metric is calculated by deducting intangible assets (zł21.33 Million) from net assets (zł528.78 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Celon Pharma SA (CLN) shareholders funds for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Celon Pharma SA Tangible Net Worth Ratio (2012–2025)
This chart shows how Celon Pharma SA's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 96.0%, reflecting net assets of zł528.78 Million with intangible assets of zł21.33 Million PLN. Also explore Celon Pharma SA (CLN) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Celon Pharma SA (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Celon Pharma SA from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Celon Pharma SA.
| Year | Tangible NW Ratio | Net Assets (PLN) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | zł363.25 Million | zł0.00 | zł457.46 Million | ▲ +1.8 pp |
| 2024 | 98.2% | zł445.21 Million | zł8.15 Million | zł543.79 Million | ▲ +1.5 pp |
| 2023 | 96.6% | zł445.56 Million | zł14.97 Million | zł569.31 Million | ▲ +2.5 pp |
| 2022 | 94.1% | zł479.65 Million | zł28.12 Million | zł608.93 Million | ▼ -0.6 pp |
| 2021 | 94.7% | zł554.00 Million | zł29.17 Million | zł707.14 Million | ▲ +4.2 pp |
| 2020 | 90.5% | zł434.67 Million | zł41.09 Million | zł703.64 Million | ▼ -8.1 pp |
| 2019 | 98.6% | zł445.04 Million | zł6.16 Million | zł591.35 Million | ▲ +0.3 pp |
| 2018 | 98.3% | zł448.73 Million | zł7.41 Million | zł563.67 Million | ▼ -1.1 pp |
| 2017 | 99.4% | zł439.85 Million | zł2.64 Million | zł525.05 Million | ▲ +0.2 pp |
| 2016 | 99.2% | zł402.50 Million | zł3.36 Million | zł464.32 Million | ▲ +2.1 pp |
| 2015 | 97.1% | zł100.82 Million | zł2.97 Million | zł168.29 Million | ▼ -1.6 pp |
| 2014 | 98.7% | zł69.62 Million | zł904.73K | zł105.44 Million | ▼ -0.5 pp |
| 2013 | 99.2% | zł52.20 Million | zł407.81K | zł82.59 Million | ▲ +0.1 pp |
| 2012 | 99.1% | zł55.57 Million | zł479.61K | zł69.80 Million | — |